Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity https://www.biorxiv.org/content/10.1101/2023.08.02.551593v1?med=mas
Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity https://www.biorxiv.org/content/10.1101/2023.08.02.551593v1?med=mas